1. Home
  2. SSNC vs BNTX Comparison

SSNC vs BNTX Comparison

Compare SSNC & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SS&C Technologies Holdings Inc.

SSNC

SS&C Technologies Holdings Inc.

HOLD

Current Price

$89.60

Market Cap

21.7B

Sector

Technology

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$94.73

Market Cap

24.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSNC
BNTX
Founded
1986
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.7B
24.8B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
SSNC
BNTX
Price
$89.60
$94.73
Analyst Decision
Strong Buy
Buy
Analyst Count
9
11
Target Price
$101.11
$137.40
AVG Volume (30 Days)
1.2M
1.6M
Earning Date
02-05-2026
11-03-2025
Dividend Yield
1.21%
N/A
EPS Growth
20.69
N/A
EPS
3.37
N/A
Revenue
$6,148,400,000.00
$3,698,814,972.00
Revenue This Year
$8.28
$2.03
Revenue Next Year
$5.86
N/A
P/E Ratio
$26.60
N/A
Revenue Growth
6.67
3.70
52 Week Low
$69.61
$81.20
52 Week High
$91.07
$129.27

Technical Indicators

Market Signals
Indicator
SSNC
BNTX
Relative Strength Index (RSI) 67.61 44.49
Support Level $85.85 $91.32
Resistance Level $89.33 $96.19
Average True Range (ATR) 1.25 2.06
MACD 0.23 0.30
Stochastic Oscillator 99.42 41.78

Price Performance

Historical Comparison
SSNC
BNTX

About SSNC SS&C Technologies Holdings Inc.

SS&C Technologies provides software products and software-enabled services to a variety of customers primarily in financial services but also healthcare firms. Acquisitions are a large part of SS&C's history. SS&C GlobeOp provides fund administration services to alternative and traditional asset managers. In addition, SS&C provides portfolio accounting, portfolio management, trading, banking/lending, and other software to asset managers, banks, and financial advisors. SS&C's purchase of Intralinks makes it a leading player in virtual deal room solutions. With its 2018 purchase of DST Systems, SS&C gained a foothold in the healthcare industry with pharmacy health management solutions and medical claim administration services. In 2022, SS&C completed the acquisition of Blue Prism.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: